FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

WAITE CHARLES P JR
2. Issuer Name and Ticker or Trading Symbol

COMPLETE GENOMICS INC [ GNOM ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O OVP VENTURE PARTNERS, 1010 MARKET STREET
3. Date of Earliest Transaction (MM/DD/YYYY)

11/16/2010
(Street)

KIRKLAND, WA 98033
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.001   11/16/2010     C    309433   A   (1) 309433   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     C    252521   A   (3) 561954   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     C    173548   A   (4) 735502   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     C    722185   A   (5) 1457687   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     C    828829   A   (5) 2286516   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     X    444591   A $1.50   2731107   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     F    74099   D $9.00   2657008   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     X    31717   A $7.56   2688725   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     F    26643   D $9.00   2662082   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     X    33832   A $7.56   2695914   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     F    28419   D $9.00   2667495   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     X    11258   A $7.56   2678753   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     F    9457   D $9.00   2669296   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     X    1088   A $7.56   2670384   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     F    914   D $9.00   2669470   I   See Footnote   (2)
Common Stock, par value $0.001   11/16/2010     C    6313   A   (1) 6313   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     C    5150   A   (3) 11463   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     C    3535   A   (4) 14998   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     C    9477   A   (5) 24475   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     C    4767   A   (5) 29242   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     X    3134   A $1.50   32376   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     F    523   D $9.00   31853   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     X    647   A $7.56   32500   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     F    544   D $9.00   31956   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     X    690   A $7.56   32646   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     F    580   D $9.00   32066   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     X    79   A $7.56   32145   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     F    67   D $9.00   32078   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     X    7   A $7.56   32085   I   See Footnote   (7)
Common Stock, par value $0.001   11/16/2010     F    6   D $9.00   32079   I   See Footnote   (7)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Preferred Stock   (1)   (1) 11/16/2010     C         309433      (8)   (9) Common Stock   309433     (1) 0   I   See Footnote   (2)
Series A Preferred Stock   (1)   (1) 11/16/2010     C         6313      (8)   (9) Common Stock   6313     (1) 0   I   See Footnote   (7)
Series B Preferred Stock   (3)   (3) 11/16/2010     C         252521      (8)   (9) Common Stock   252521     (3) 0   I   See Footnote   (2)
Series B Preferred Stock   (3)   (3) 11/16/2010     C         5150      (8)   (9) Common Stock   5150     (3) 0   I   See Footnote   (7)
Series C Preferred Stock   (4)   (4) 11/16/2010     C         173548      (8)   (9) Common Stock   173548     (4) 0   I   See Footnote   (2)
Series C Preferred Stock   (4)   (4) 11/16/2010     C         3535      (8)   (9) Common Stock   3535     (4) 0   I   See Footnote   (7)
Series D Preferred Stock   (5)   (5) 11/16/2010     C         722185      (8)   (9) Common Stock   722185     (5) 0   I   See Footnote   (6)
Series D Preferred Stock   (5)   (5) 11/16/2010     C         9477      (8)   (9) Common Stock   9477     (5) 0   I   See Footnote   (7)
Series E Preferred Stock   (5)   (5) 11/16/2010     C         828829      (8)   (9) Common Stock   828829     (5) 0   I   See Footnote   (2)
Series E Preferred Stock   (5)   (5) 11/16/2010     C         4767      (8)   (9) Common Stock   4767     (5) 0   I   See Footnote   (7)
Warrant to Purchase Common Stock   $1.50   11/16/2010     X         444591      (10) 8/12/2016   Common Stock   444591   $0   0   I   See Footnote   (2)
Warrant to Purchase Common Stock   $1.50   11/16/2010     X         3134      (10) 8/12/2016   Common Stock   3134   $0   0   I   See Footnote   (7)
Warrant to Purchase Series B Preferred Stock   (3) $11.642   (6) 11/16/2010     J   (11)       906      (10) 2/21/2012   Common Stock   906   $0   0   I   See Footnote   (2)
Warrant to Purchase Series B Preferred Stock   (3) $11.642   (6) 11/16/2010     J   (11)       17      (10) 2/21/2012   Common Stock   17   $0   0   I   See Footnote   (7)
Warrant to Purchase Series B Preferred Stock   (3) $11.642   (6) 11/16/2010     J   (11)       237      (10) 3/12/2012   Common Stock   237   $0   0   I   See Footnote   (2)
Warrant to Purchase Series D Preferred Stock   (5) $7.56   11/16/2010     X         31717      (10) 2/13/2014   Common Stock   31717   $0   0   I   See Footnote   (2)
Warrant to Purchase Series D Preferred Stock   (5) $7.56   11/16/2010     X         647      (10) 2/13/2014   Common Stock   647   $0   0   I   See Footnote   (7)
Warrant to Purchase Series D Preferred Stock   (5) $7.56   11/16/2010     X         33832      (10) 4/6/2014   Common Stock   33832   $0   0   I   See Footnote   (2)
Warrant to Purchase Series D Preferred Stock   (5) $7.56   11/16/2010     X         690      (10) 4/6/2014   Common Stock   690   $0   0   I   See Footnote   (7)
Warrant to Purchase Series D Preferred Stock   (5) $7.56   11/16/2010     X         11258      (10) 6/12/2014   Common Stock   11258   $0   0   I   See Footnote   (2)
Warrant to Purchase Series D Preferred Stock   (5) $7.56   11/16/2010     X         79      (10) 6/12/2014   Common Stock   79   $0   0   I   See Footnote   (7)
Warrant to Purchase Series D Preferred Stock   (5) $7.56   11/16/2010     X         1088      (10) 8/5/2014   Common Stock   1088   $0   0   I   See Footnote   (2)
Warrant to Purchase Series D Preferred Stock   (5) $7.56   11/16/2010     X         7      (10) 8/5/2014   Common Stock   7   $0   0   I   See Footnote   (7)

Explanation of Responses:
( 1)  Each share of Series A Preferred Stock was automatically converted into common stock immediately prior to the completion of the Issuer's initial public offering. Shares are reported on an "as converted" basis giving effect to the 4.615101 conversion ratio applicable to such shares.
( 2)  The shares are owned by OVP Venture Partners VI, L.P. ("OVP VI"). OVMC VI, LLC ("OVMC VI LLC") serves as the general partner of OVP VI. Charles P. Waite, Jr. is a managing member of OVMC VI LLC and shares voting and investment power over the shares held by OVP VI. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.
( 3)  Each share of Series B Preferred Stock was automatically converted into common stock immediately prior to the completion of the Issuer's initial public offering. Shares are reported on an "as converted" basis giving effect to the 5.926613 conversion ratio applicable to such shares.
( 4)  Each share of Series C Preferred Stock was automatically converted into common stock immediately prior to the completion of the Issuer's initial public offering. Shares are reported on an "as converted" basis giving effect to the 8.241076 conversion ratio applicable to such shares.
( 5)  Each share of Series D and Series E Preferred Stock was automatically converted into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering.
( 6)  The Exercise Price of the Warrant to Purchase Series B Preferred Stock is $69.00 per share of Series B Preferred Stock. The exercise price is reported on an "as converted" basis after giving effect to the 5.926613 conversion ratio.
( 7)  The shares are owned by OVP VI Entrepreneurs Fund, L.P. ("OVP VI Entrepreneurs"). OVMC VI LLC serves as the general partner of OVP VI Entrepreneurs. Charles P. Waite, Jr. is a managing member of OVMC VI LLC and shares voting and investment power over the shares held by OVP VI Entrepreneurs. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.
( 8)  The securities are immediately convertible.
( 9)  The expiration date is not relevant to the conversion of these securities.
( 10)  The warrant is immediately exercisable.
( 11)  Warrant canceled pursuant to its terms current with closing of Issuer's initial public offering.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
WAITE CHARLES P JR
C/O OVP VENTURE PARTNERS
1010 MARKET STREET
KIRKLAND, WA 98033
X X


Signatures
/s/ Charles P. Waite, Jr. 11/16/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Global X Genomics and Bi... (NASDAQ:GNOM)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Global X Genomics and Bi... Charts.
Global X Genomics and Bi... (NASDAQ:GNOM)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Global X Genomics and Bi... Charts.